Global GPCR Screening Market Growth (Status and Outlook) 2023-2029

Global GPCR Screening Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “GPCR Screening Industry Forecast” looks at past sales and reviews total world GPCR Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected GPCR Screening sales for 2023 through 2029. With GPCR Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GPCR Screening industry.

This Insight Report provides a comprehensive analysis of the global GPCR Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GPCR Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GPCR Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GPCR Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GPCR Screening.

The global GPCR Screening market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for GPCR Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for GPCR Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for GPCR Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key GPCR Screening players cover Thermo Fisher Scientific, PerkinElmer, Merck, Molecular Devices, Promega, Cisbio, Discoverx, Enzo Life Sciences and Pharmaron, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of GPCR Screening market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Calcium Flux Screening
cAMP Screening
Others

Segmentation by application
Oncology
Cardiovascular System
Central Nervous System
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
PerkinElmer
Merck
Molecular Devices
Promega
Cisbio
Discoverx
Enzo Life Sciences
Pharmaron
Innoprot
Euroscreen
ArcoScreen
Profacgen
Creative BioMart
Hamamatsu Photonics
Reaction Biology

Please note: The report will take approximately 2 business days to prepare and deliver.